Ascent Industries Co. ( ACNT ) is no longer a mixed chemicals-and-tubing business but a pure-play specialty chemicals company. They now focus on supply solutions for industrial customers. And, operationally speaking, ACNT has a hybrid model. Basically, they function as aMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a gra ...

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential opportunities for traders [1] Premarket Gainers - Brand Engagement Network, Inc. (BNAI) is up 20% at $51.61 [3] - Latham Group, Inc. (SWIM) is up 20% at $7.79 [3] - Evolus, Inc. (EOLS) is up 14% at $4.74 [3] - Edesa Biotech, Inc. (EDSA) is up 11% at $4.86 [3] - 20/20 Biolabs, Inc. (AIDX) is up 11% at $3.28 [3] - DeFi Development Corp. (DFDV) is up 9% at $4.04 [3] - Accel Entertainment, Inc. (ACEL) is up 7% at $11.95 [3] - Solana Company (HSDT) is up 7% at $2.12 [3] - Nano-X Imaging Ltd. (NNOX) is up 6% at $2.76 [3] - Strive Asset Management, LLC (ASST) is up 5% at $8.81 [3] Premarket Losers - Battalion Oil Corporation (BATL) is down 28% at $19.67 [4] - TMD Energy Limited (TMDE) is down 24% at $3.03 [4] - Ascent Industries Co. (ACNT) is down 15% at $14.75 [4] - indie Semiconductor, Inc. (INDI) is down 14% at $2.71 [4] - WEBTOON Entertainment Inc. (WBTN) is down 13% at $9.98 [4] - STAAR Surgical Company (STAA) is down 10% at $17.00 [4] - Indonesia Energy Corporation Limited (INDO) is down 10% at $4.68 [4] - BiomX Inc. (PHGE) is down 7% at $4.52 [4] - Arbutus Biopharma Corporation (ABUS) is down 6% at $4.37 [4] - Global Interactive Technologies, Inc. (GITS) is down 6% at $2.43 [4]

CFO Ryan (no last name provided on the call) said net sales increased 4% year-over-year in the fourth quarter, supported by a 6% lift in shipments as higher-throughput programs ramped. However, the incremental volume skewed toward lower-priced, lower-margin wins, compressing spreads. Gross profit in the quarter was essentially flat versus the prior-year period, down less than $50,000, while gross margin declined by approximately 90 basis points.Management said fourth-quarter performance was affected by cont ...

Financial Data and Key Metrics Changes - The company exited 2025 as a pure-play specialty chemical company with a gross margin expansion of nearly 1,000 basis points and a gross profit increase of 61% [3] - Adjusted EBITDA improved by more than $4 million year-over-year despite operating on approximately 7% lower revenue [3][4] - For the fourth quarter, net sales increased by 4% year-over-year, supported by a 6% lift in shipments [12] - Full year net sales declined by 7.2% due to a 17.7% contraction in demand, which more than offset a 10.9% pricing action [12][14] - SG&A expenses increased to $6.5 million from $5.4 million in the prior year period, influenced by litigation settlement expenses [14][15] Business Line Data and Key Metrics Changes - Product sales represented 47% of the wins in the fourth quarter, with custom manufacturing contributing the balance [5] - The company added a record $43.4 million of new selling projects while sunsetted $40.8 million [6] - The pipeline conversion reached 25% in Q4, winning 38 projects across 23 customers with an average sales cycle of 2.9 months [5] Market Data and Key Metrics Changes - The fourth quarter reflected continued end market softness and unfavorable mix, which pressured absorption and led to sequential moderation in margin and adjusted EBITDA [4] - The company is reshaping its book of business towards higher-margin, lower-volatility revenue, which may create short-term variability [4] Company Strategy and Development Direction - The company aims to deepen customer partnerships through innovation, reliability, and speed while preserving balance sheet strengths and allocating capital with discipline [11] - The focus is on building a stronger company regardless of market cycles and positioning it for compounding growth [11] - The company is investing in capabilities rather than expanding capacity, revitalizing existing assets to improve utilization without increasing structural overhead [9][42] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand environment remains uneven, with inherent seasonality challenges affecting business stability [22] - The company is confident in its ability to pass along raw material cost increases to customers, indicating a strong position against potential cost pressures [24] - Management expressed optimism about achieving double-digit revenue growth for 2026 based on new business wins and existing pipeline [25][26] Other Important Information - The company ended the year with significant liquidity, no debt, and a clean balance sheet, which provides resilience in a soft demand environment [10][16] - The cash conversion cycle was reduced to 61 days, demonstrating tighter working capital discipline [17] Q&A Session Summary Question: Insights on quarterly cadence and macro environment - Management acknowledged inherent seasonality challenges and noted some softness in demand towards the end of the quarter [22] Question: Outlook for 2026 revenue growth - Management confirmed plans for double-digit revenue growth based on new business wins and existing pipeline [25][26] Question: Gross margin expectations - Management indicated targets of 30%-35% gross margins in the long term, with current performance in the upper 20s to lower 30s range [27][28] Question: Clarification on new business wins - Management clarified that $9.4 million of business was won in Q4, with $7.1 million attributed to a new customer program [36] Question: M&A environment and appetite - Management remains open to M&A but emphasizes the need for the right opportunities that align with their operational goals [61]

Financial Data and Key Metrics Changes - The company exited 2025 as a pure-play specialty chemical company with a gross margin expansion of nearly 1,000 basis points and a gross profit increase of 61% despite a 7% lower revenue [3][4] - For the fourth quarter, net sales increased by 4% year-over-year, supported by a 6% lift in shipments, although full-year net sales declined by 7.2% due to a 17.7% contraction in demand [12][14] - Adjusted EBITDA for the quarter was a loss of $1.1 million, a decrease of approximately $600,000 year-over-year, while full-year EBITDA improved by $4.1 million year-over-year [15][16] Business Line Data and Key Metrics Changes - Product sales accounted for 47% of new wins, with custom manufacturing contributing the remainder; the company added a record $43.4 million in new selling projects while sunsetted $40.8 million [5][6] - The company secured a significant new commercial program expected to generate over $10 million in incremental annualized revenue, contributing to improved operating leverage across two manufacturing sites [5][6] Market Data and Key Metrics Changes - The fourth quarter results reflected continued end market softness and an unfavorable mix, which pressured absorption and led to a sequential moderation in margin and adjusted EBITDA [4] - The cash conversion cycle was reduced to 61 days, indicating tighter working capital discipline and increased resilience in a soft demand environment [16] Company Strategy and Development Direction - The company is focused on reshaping its business towards higher-margin, lower-volatility revenue, aiming to deepen customer partnerships through innovation, reliability, and speed [4][11] - The strategy includes modernizing the demand engine, enhancing marketing, sales, R&D, and operations to improve coordination and earnings quality [7][8] Management's Comments on Operating Environment and Future Outlook - Management acknowledged inherent seasonality challenges and expressed confidence in the ability to pass along raw material cost increases to customers, indicating a well-protected position against market fluctuations [24] - The company aims for double-digit revenue growth in 2026 based on new business wins and existing customer relationships, with a target gross margin in the 30%-35% range over the long term [26][27][28] Other Important Information - The company ended the year with significant liquidity, no debt, and a clean balance sheet, allowing for flexibility in capital allocation and investment opportunities [10][16] - The company has removed over $5 million in labor, overhead, and other costs compared to 2024, strengthening the business while lowering the structural cost base [7] Q&A Session Summary Question: Insights on quarterly cadence and macro environment - Management noted some inherent seasonality challenges and a slight softness in demand in Q4, with plans to build a more stable book of business [22][23] Question: Outlook for 2026 revenue growth - Management confirmed plans for double-digit revenue growth in 2026, supported by new business scaling and existing customer revenues [25][26] Question: Gross margin expectations - Management indicated targets for gross margins in the mid-20s to low 30s range, with confidence in achieving these despite quarterly fluctuations [27][28][46] Question: Clarification on new business wins - Management clarified that $9.4 million of business was won in Q4, with $7.1 million attributed to a new customer program, and the potential for further growth [35][36][37] Question: Capital allocation strategy - Management emphasized a focus on reinvestments in assets and capabilities first, with share buybacks and M&A considered opportunistically [52][54]

Financial Data and Key Metrics Changes - The company exited 2025 as a pure-play specialty chemical company with a gross margin expansion of nearly 1,000 basis points and a gross profit increase of 61% despite a 7% lower revenue year-over-year [3][4] - For Q4, net sales increased by 4% year-over-year, supported by a 6% lift in shipments, while full-year net sales declined by 7.2% due to a 17.7% contraction in demand [11][12] - Adjusted EBITDA for Q4 was a loss of $1.1 million, a decrease of approximately $600,000 year-over-year, while full-year EBITDA improved by $4.1 million year-over-year [13] Business Line Data and Key Metrics Changes - The company secured a significant new commercial program expected to generate over $10 million in incremental annualized revenue, contributing to improved operating leverage across two manufacturing sites [5] - In Q4, the company added a record $43.4 million in new selling projects while sunsetted $40.8 million, reflecting a strategic shift towards higher-margin, lower-volatility revenue [6] Market Data and Key Metrics Changes - The fourth quarter results reflected continued end market softness and an unfavorable mix, which pressured absorption and led to a sequential moderation in margin and adjusted EBITDA [4] - The cash conversion cycle was reduced to 61 days, indicating tighter working capital discipline and increased resilience in a soft demand environment [15] Company Strategy and Development Direction - The company is focused on deepening customer partnerships through innovation, reliability, and speed while preserving balance sheet strengths and allocating capital with discipline [10] - The management emphasized that they are not waiting for market recovery but are building a stronger company regardless of the cycle [10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged inherent seasonality challenges and indicated a plan to build a more stable book of business to minimize the impact of seasonal volatility [20] - The company is targeting double-digit revenue growth for 2026 based on new business wins and existing pipeline [23] Other Important Information - The company ended the year with significant liquidity, no debt, and a clean balance sheet, which provides flexibility for future investments [14] - SG&A expenses increased to $6.5 million in Q4 compared to $5.4 million in the prior year, influenced by litigation settlement expenses and legacy activity [13] Q&A Session Summary Question: Insights on quarterly cadence and macro environment - Management noted that demand softness developed late in Q4 and highlighted ongoing seasonality challenges [20] Question: Outlook for 2026 revenue growth - Management confirmed plans for double-digit revenue growth in 2026 based on new business scaling [23] Question: Clarification on new business wins - Management clarified that $9.4 million of business was won in Q4, with $7.1 million attributed to a new customer program [33] Question: Capacity expansion decisions - Management explained that investments were made to expand capabilities rather than capacity, focusing on revitalizing existing assets [39] Question: Gross margin outlook - Management indicated that Q4 margin compression was due to mix effects and that targets of 30% gross margins remain achievable [45] Question: M&A environment and appetite - Management expressed ongoing interest in M&A but emphasized the need for the right opportunities that align with their operational goals [57]

Financial Performance - For the full-year 2025, net sales from continuing operations decreased by $5.8 million, or 7.2%, to $74.9 million compared to 2024, primarily due to a 17.7% decrease in pounds shipped, partially offset by a 10.9% increase in average selling prices[133]. - Gross profit from continuing operations increased by 61.0% to $17.2 million, or 23.0% of sales, compared to $10.7 million, or 13.2% of sales, in 2024, driven by improved strategic sourcing initiatives and operational efficiencies[134]. - Selling, general and administrative expenses (SG&A) increased by $3.2 million to $24.1 million in 2025, representing 32.1% of sales, up from 25.9% in 2024, due to strategic investments and increased operational costs[135]. - The operating loss from continuing operations improved to $7.0 million in 2025 from $10.8 million in 2024, primarily due to increased gross profit and non-cash lease modification gains[136]. - Interest income for 2025 was $0.8 million compared to interest expense of $0.3 million in 2024, attributed to a higher interest-bearing cash balance[142]. - Consolidated EBITDA for 2025 was $(2.1) million, an improvement from $(5.8) million in 2024, while Adjusted EBITDA was $(0.6) million compared to $(4.7) million in 2024[147]. - Specialty Chemicals segment net sales decreased by 7.2%, or $5.8 million, to $74.9 million in 2025, with SG&A expenses increasing by 40.0% to $13.4 million[138][139]. - Specialty Chemicals Adjusted EBITDA increased to $8.1 million in 2025, or 10.8% of segment sales, compared to $6.3 million, or 7.8% of segment sales, in 2024[148]. - Total net sales for the year ended December 31, 2025, were $74,942,000, a decrease of 7.3% compared to $80,763,000 in 2024[194]. - Gross profit increased to $17,212,000 in 2025, up from $10,692,000 in 2024, reflecting a gross margin improvement[194]. - The operating loss from continuing operations narrowed to $7,027,000 in 2025 from $10,802,000 in 2024[194]. - Net income for 2025 was $867,000, a significant recovery from a net loss of $13,598,000 in 2024[194]. - Cash flows from operating activities for continuing operations resulted in a net cash outflow of $7,269,000 in 2025, compared to a net cash inflow of $977,000 in 2024[195]. - The company reported a net cash inflow of $50,981,000 from investing activities in 2025, a substantial increase from $905,000 in 2024[195]. - Total cash and cash equivalents at the end of 2025 increased to $57,606,000, up from $16,108,000 at the end of 2024[195]. Customer and Market Dynamics - The top five customers accounted for approximately 51% of revenues in 2025, compared to 35% in 2024, indicating increased customer concentration risk[21]. - The top five customers account for approximately 51% of revenues for 2025 and 35% for 2024, indicating a significant dependency on a limited customer base[53]. - The specialty chemicals sector faces rapid innovation and pricing pressures, which can lead to volatility in sales and margins[54]. - The financial health of customers and suppliers can impair demand and pricing, potentially leading to reduced sales and cash flow[63]. Operational and Strategic Initiatives - The Company completed the sale of assets related to BRISMET for approximately $45 million in cash on April 4, 2025, with $4.5 million placed in escrow[29]. - The Company sold assets related to ASTI for approximately $16 million in cash on June 30, 2025, with $0.8 million placed in escrow[30]. - The Chemicals-as-a-Service (CaaS) strategy was introduced in 2025, focusing on integrated services beyond just product offerings[15]. - The company has strengthened its R&D capabilities through targeted talent acquisition, enhancing its ability to develop and commercialize differentiated solutions[24]. - The company has exited the Tubular Products Segment, focusing solely on the Specialty Chemicals Segment, which may lead to unexpected costs and liabilities[94]. - The exit from the Tubular Products Segment increases dependence on the Specialty Chemicals Segment, amplifying risks from raw material price volatility and supply chain disruptions[95]. - The company may pursue acquisitions and strategic investments to expand its specialty chemicals platform, but success is not guaranteed[96]. Workforce and Labor Relations - The voluntary turnover rate for the Company in 2025 was approximately 27%, reflecting normal workforce movement and organizational changes[36]. - The average employee tenure is approximately 9 years, indicating workforce stability and institutional experience[36]. - As of December 31, 2025, 54 employees (approximately 27% of total employees) are represented by unions, which could lead to labor disruptions if collective bargaining agreements are not renewed[88]. - The company faces risks associated with maintaining a skilled workforce, which may increase labor costs and limit growth initiatives[90]. Financial Position and Liquidity - As of December 31, 2025, the company held $57.6 million in cash and cash equivalents and $11.4 million in available capacity on its revolving line of credit[150]. - The current ratio improved to 6.7 in 2025 from 2.8 in 2024, indicating a stronger liquidity position[163]. - The company has not declared or paid dividends in 2024 or 2025 due to restrictions in its credit agreement[122]. - Total assets decreased to $111,937,000 in 2025 from $147,250,000 in 2024, primarily due to the reduction in current assets[193]. - Total liabilities were reduced to $24,945,000 in 2025 from $53,705,000 in 2024, reflecting a significant decrease in financial obligations[193]. - Retained earnings increased to $45,786,000 in 2025 from $44,919,000 in 2024, indicating positive earnings retention[193]. Risks and Challenges - Raw material prices are subject to volatility, and significant increases may adversely impact margins if not passed through to customers[61]. - The company is dependent on the timely availability of raw materials, and any interruptions could materially affect financial results[57]. - The company actively manages sourcing strategies to mitigate supply risks, but disruptions from geopolitical developments or other unforeseen circumstances could still occur[58]. - The company is exposed to environmental, health, and safety liabilities, which could have a material adverse effect on financial condition[75]. - Changes in tax laws or rates may materially affect future cash taxes and overall profitability[84]. - The company has identified material weaknesses in internal controls over financial reporting, which may affect investor confidence and the market price of its securities[102]. - The company leverages AI tools to enhance innovation and operational performance, but this also introduces risks related to legal and regulatory compliance[108]. - The allowance for credit losses increased to $1,004,000 in 2025 from $202,000 in 2024, indicating a rise in expected credit losses[208]. - Inventory adjustments for lower of cost or net realizable value (LCNRV) were $200,000 in 2025, compared to $500,000 in 2024[209]. Shareholder Activities - The company repurchased 19,749 shares of common stock in Q4 2025 at an average price of $13.23, with a new repurchase program authorized for up to 2.0 million shares over 24 months[124]. - The company repurchased a total of 745,524 shares in 2025 at an average price of $12.26 per share, totaling $9,159,661[162]. - The company issued 41,832 shares of common stock from treasury in 2025, resulting in a capital reduction of $436,000[196].

Exhibit 99.1 Schaumburg, Illinois, March 3, 2026 – Ascent Industries Co. (Nasdaq: ACNT) ("Ascent" or the "Company"), a specialty chemicals platform delivering differentiated, performance-driven chemical solutions, is reporting its results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Summary 1 | (in millions, except per share and margin) | Q4 2025 | Q4 2024 | Change | | --- | --- | --- | --- | | Net Sales | $18.8 | $18.1 | 3.9% | | Gross Profit | $3.4 | $3.5 | (2.9)% | | Gross ...

Core Insights - The article discusses the rarity of micro-cap companies successfully executing strategic pivots without significantly diluting shareholder value, emphasizing the importance of cash reserves and debt management during such transitions [1] Group 1: Investment Strategy - The focus is on identifying mispriced opportunities in the market, particularly where valuations are disconnected from underlying economic realities [1] - The investment approach prioritizes cash flow durability, balance sheet strength, and the risks associated with various capital structures [1] - There is a particular interest in cyclical industries, energy, industrials, and under-followed mid-cap companies, where market expectations often diverge from actual performance [1] Group 2: Market Sentiment - The article highlights the potential for significant stock price changes when market sentiment lags behind improving fundamentals, especially in companies that have already faced market punishment [1] - Asymmetric setups are sought after, where modest changes in market expectations can lead to substantial stock price movements [1] Group 3: Communication and Engagement - The author shares investment ideas and analysis through Seeking Alpha, inviting readers to challenge and critique the investment thesis presented [1]

Core Insights - The presentation is led by the President and CEO of Ascent Industries Company, highlighting the leadership team's experience and past successes in turnaround situations [1] - The CEO emphasizes the importance of learning from previous experiences, particularly from their time at Clearon, where they transformed a company from a loss of $8 million in adjusted EBITDA to a profit of $36 million over approximately 4.5 years [2] Company Background - Ascent Industries is led by a team with a decade of collaboration, including the CFO, who has a history of working together in various companies [1] - The leadership team has a proven track record in improving financial performance in the specialty chemical sector, indicating a strong capability in managing and turning around underperforming companies [2]